Fostering Communications in the Drug Development Process

Feb 8, 2018

In this article, Deborah A. Komlos at Clarivate Analytics describes the high importance of the communications between sponsors and the US Food and Drug Administration (FDA) in the process of drug development, having a shared public health goal of early ...

Read More

Powering Clinical Trials: Achieving Relevance

Feb 8, 2018

Enrolling insufficient numbers of subjects to power a clinical study is often cited as a major reason for failure to achieve statistically significant endpoint or high probability or relevance for data. Simply using greater numbers of subjects to overcome inherent ...

Read More